Dexmedetomidine in Dextrose
Dexmedetomidine · Injection · Intravenous
Current shortage
Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 44567-602-24) – Available (HQ Specialty Pharma, updated Aug 17, 2026)
Marketed by WG Critical Care
Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 44567-603-24) – Available (HQ Specialty Pharma, updated Aug 17, 2026)
Marketed by WG Critical Care
No FDA structured label text is available for Dexmedetomidine in Dextrose. The NDC listings below come from the FDA National Drug Code directory.
Active ingredients
- Dexmedetomidine Hydrochloride in 2 products
Dexmedetomidine in Dextrose NDC products (2)
| NDC | Strength & form | Labeler | Type |
|---|---|---|---|
| 44567-602 | Dexmedetomidine Hydrochloride 4 ug/mL Injection | WG Critical Care, LLC | NDA |
| 44567-603 | Dexmedetomidine Hydrochloride 4 ug/mL Injection | WG Critical Care, LLC | NDA |
Frequently asked questions
Who makes Dexmedetomidine in Dextrose?
Dexmedetomidine in Dextrose is listed by 1 labeler in the FDA NDC directory, including WG Critical Care, LLC.